Oncologists Push for Age Inclusive Use of Cancer Treatments

Oncologists push for age inclusive use of cancer treatments

Recent advances have resulted in highly effective "tissue-agnostic" drugs that treat cancers based on their molecular markers rather than their tissue of origin, but very few of these drugs are approved for use in children.

Reimagining cancer care for a new generation of patients - The Cancer Letter

The landscape of cancer is shifting beneath our feet, and we must adapt our clinical practice accordingly.  Cancer rates in women under 50 are now 82% higher than in men of the same age — a statistic that should fundamentally reshape how we approach oncological care.  At City of Hope, we’re witnessing rising cases across multiple cancer types: lymphoma, melanoma, thyroid, breast, lung, cervical, and ovarian cancers are increasingly affecting you…

Oncologists Advocate for Licensing Cancer Treatments Across All Age Groups

In recent years, the landscape of oncology has witnessed transformative advancements with the emergence of “tissue-agnostic” cancer therapies — a novel class of precision medicines engineered to target cancers based not on their anatomical origin but on their underlying molecular signatures. These therapies represent a quantum leap in oncological treatment paradigms, harnessing genomic and proteomic insights to intervene at the very molecular dr…